Allergic Rhinitis Market Report 2026

Allergic Rhinitis Market Overview

• Allergic Rhinitis market size has reached to $15.69 billion in 2025 • Expected to grow to $19.58 billion in 2030 at a compound annual growth rate (CAGR) of 4.7% • Growth Driver: Air Pollution And Climate Change Fueling Growth In The Allergic Rhinitis Market • Market Trend: Dual-Action Allergy Therapy Expands Treatment Options In India • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Allergic Rhinitis Market?

Allergic rhinitis refers to an allergic reaction involving nasal inflammation brought on by an allergen, such as pollen, dust, mold, or animal skin flakes, resulting in sneezing, lung congestion, an itchy nose and a sore throat. Allergic rhinitis is treated with various allergy drugs in various dosage forms that help alleviate symptoms. The main types of allergic rhinitis are seasonal allergic rhinitis, perennial allergic rhinitis and occupational allergic rhinitis. Seasonal allergic rhinitis (SAR) refers to a kind of allergic rhinitis that is characterized by the rapid and repeatable onset and resolution of symptoms like allergic reactions linked to pollen exposure. The various treatments include antihistamines, corticosteroids, immunotherapy, decongestants, others with various tests such as skin tests, IgE radioallergosorbent test and complete blood count. The various routes of administration include oral, nasal and others. These are distributed through various distribution channels such as hospital pharmacies, retail pharmacies and online stores.

What Is The Allergic Rhinitis Market Growth Forecast?

The allergic rhinitis market size is expected to see steady growth in the next few years. It will grow to $19.58 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to advances in immunotherapy treatments, rising demand for personalized allergy management, increasing adoption of online pharmacies, technological improvements in ige rast and blood tests, expansion of global allergy treatment markets. Major trends in the forecast period include rising prevalence of allergic rhinitis worldwide, increased use of immunotherapy and personalized treatments, growing adoption of nasal corticosteroids and antihistamines, expansion of online pharmacies and e-commerce distribution, enhanced diagnostic testing including skin and ige rast tests.

Global Allergic Rhinitis Market Segmentation

1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis 2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments 3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test 4) By Route Of Administration: Oral, Nasal, Other Route Of Administration 5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores Subsegments: 1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy 2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy 3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens

What Is The Driver Of The Allergic Rhinitis Market?

High levels of air pollution and climate change are expected to propel the growth of the allergic rhinitis market going forward. Air pollution refers to the presence of harmful substances in the Earth's atmosphere that can adversely affect human health, the environment and the quality of the air we breathe. Climate change refers to long-term alterations in the Earth's climate patterns, including temperature, precipitation and other climatic factors. Air pollution has been increasingly recognized as a significant environmental factor contributing to the prevalence and worsening of allergic rhinitis, highlighting the intricate relationship between air quality and respiratory health. For instance, in August 2024, according to the United States Environmental Protection Agency, a US-based Government agency, in 2023, approximately 66 million tons of pollutants were released into the atmosphere across the United States. Therefore, high levels of air pollution and climate change drive the allergic rhinitis industry.

Key Players In The Global Allergic Rhinitis Market

Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd.

Global Allergic Rhinitis Market Trends and Insights

Major companies operating in the allergic rhinitis market are focusing on developing innovative products such as combination allergy therapies to enhance multi-pathway symptom relief and improve long-term management of allergic conditions. A combination allergy therapy is a dual-action formulation that combines different classes of active ingredients to deliver broader and more effective control of allergy-related inflammation. For instance, in October 2025, Cadila Pharmaceuticals, an India-based pharmaceutical manufacturer, launched Dlorfast-M Tablets. The formulation pairs Desloratadine and Montelukast to block both histamine- and leukotriene-mediated pathways, offering stronger and more comprehensive relief than either agent alone. Its once-daily dosing improves treatment adherence while broadening therapeutic options for patients with allergic rhinitis and urticaria.

What Are Latest Mergers And Acquisitions In The Allergic Rhinitis Market?

In March 2024, Shionogi & Co., Ltd., a Japan-based provider of pharmaceuticals and innovative therapeutic solutions, entered into an option agreement to acquire the exclusive global research, development, and commercialization rights to FPP004X from FunPep Co., Ltd., for $1.9 million. With this agreement, Shionogi aims to expand its allergic rhinitis pipeline by adding a novel anti-IgE antibody-inducing peptide vaccine designed to offer long-lasting relief from seasonal allergic rhinitis. FunPep Co., Ltd. is a Japan-based biotechnology company developing peptide-based therapeutics, including FPP004X, an early-stage vaccine candidate targeting IgE-mediated pollen allergy.

Regional Outlook

North America was the largest region in the allergic rhinitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Allergic Rhinitis Market?

The allergic rhinitis market consists of revenues earned by entities by providing treatments such as alternative therapies, surgeries and lifestyle modifications. The market value includes the value of related goods sold by the service provider or included within the service offering. The allergic rhinitis market also includes sales of allergy pills and injections that are used for the treatment of the disease. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Allergic Rhinitis Market Report 2026?

The allergic rhinitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the allergic rhinitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.